Share Purchase Plan Offer Booklet
Filed with ASX · · 19 pages · English
Earlier from Syntara
- $8m placement and share purchase plan
- Continuation of trading halt
- Positive FDA feedback for Amsulostat P2b trial
- Half Year Report and Appendix 4D
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Syntara
- Results of Share Purchase Plan
- Encouraging SNT-4728 Phase 2 iRBD results
- Appendix 4E and Annual Report
- Syntara expands SNT-9465 skin scarring study
- Further significant results from SNT-4728 iRBD Phase 2 trial
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara